SCHEMBL4971197

SCHEMBL4971197

Nc1ccn([C@@]2(C(=O)c3ccccc3)C[C@H](O)[C@@H](CO)O2)c(=O)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.41
PDE4D Q08499 1/20 0.41
SLC29A1 Q99808 1/20 0.41
LMNA P02545 4/20 0.41
THRB P10828 1/20 0.41
MTOR P42345 1/20 0.41
MDM2 Q00987 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
CACNA1F O60840 2/20 0.35
ALB P02768 2/20 0.35
MAPT P10636 2/20 0.35
CACNA1D Q01668 2/20 0.35
CACNA1S Q13698 2/20 0.35
CACNA1C Q13936 2/20 0.35
POLB P06746 3/20 0.34
ST6GAL1 P15907 1/20 0.34
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709959 0.91 PDE3A (0.41) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL22363161 0.89 POLA1 (0.42) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL8627861 0.85 PDE3A (0.44) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL29720484 0.84 CYP3A4 (0.35) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL6394687 0.83 RNASE1 (0.32) POLBABL1RIN1ALDH1A1ADRB1
SCHEMBL1763155 0.82 PDE3A (0.42) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL30305979 0.81 PDE4D (0.33) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL598527 0.80 ABL1 (0.40) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL5201335 0.80 TYMP (0.42) ST6GAL1
SCHEMBL10344618 0.80 DNMT1 (0.33) PDE3APDE4DSLC29A1POLBDNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114652836-A T3SS small-molecule inhibitor and screening method and application thereof 山东大学 2022-06-24 CN claimed
WO-2000075154-A2 PROTECTED NUCLEOSIDES ALLIEDSIGNAL INC. (US) 2000-12-14 WO claimed
US-12559517-B2 Oligonucleotide manufacturing method AJINOMOTO CO., INC. (JP) 2026-02-24 US disclosed
US-20260028368-A1 OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT INTEGRATED DNA TECH INC (US) 2026-01-29 US disclosed
US-12459968-B2 Oligonucleotide synthesis on solid support INTEGRATED DNA TECHNOLOGIES, INC. (US) 2025-11-04 US disclosed
CN-118005706-A Preparation method of 2',3' -dideoxynucleotide 天津奥利芙生物技术有限公司 2024-05-10 CN disclosed
CN-115721633-B Application of hydroxy alizarin as T3SS small molecule inhibitor 山东大学 2024-05-03 CN disclosed
EP-4299736-A2 HYDROLASES AND USES THEREOF Vilnius University (LT) 2024-01-03 EP disclosed
CN-112533892-B Alkoxyphenyl derivative, nucleoside protector, nucleotide protector, method for producing oligonucleotide, and method for removing substituent 藤本化学制品株式会社 2023-09-08 CN disclosed
US-20230119227-A1 OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT INTEGRATED DNA TECHNOLOGIES, INC. 2023-04-20 US disclosed
CN-115721633-A Application of hydroxyalizarin as T3SS small-molecule inhibitor 山东大学 2023-03-03 CN disclosed
WO-1992013869-A1 METHYLENE PHOSPHONATE NUCLEOSIDE ANALOGS AND OLIGONUCLEOTIDE ANALOGS MADE THEREFROM GILEAD SCIENCES, INC. (US) 1992-08-20 WO disclosed
EP-0135587-B1 DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS SYNGENE, INC. (US) 1990-05-02 EP disclosed
EP-0155950-B1 OLIGONUCLEOTIDE POLYMERIC SUPPORT SYSTEM MOLECULAR BIOSYSTEMS INC (US) 1990-01-17 EP disclosed
EP-0270651-A4 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. CALIFORNIA INST OF TECHN (US) 1989-03-29 EP disclosed
EP-0270651-A1 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. CALIFORNIA INST OF TECHN (US) 1988-06-15 EP disclosed
WO-1988000201-A1 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES CALIFORNIA INSTITUTE OF TECHNOLOGY, INC. (US) 1988-01-14 WO disclosed
EP-0191869-A1 FISH CALCITONIN DERIVATIVE, PROCESS FOR ITS PREPARATION, AND GENE SYSTEM THEREFOR HODOGAYA CHEMICAL COMPANY, LIMITED (JP) 1986-08-27 EP disclosed
EP-0115613-A2 DNA sequences, their preparation, plasmids containing these sequences and their use in the synthesis of eukaryotic gene products in prokaryotes BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) 1984-08-15 EP disclosed
EP-0058954-A2 Tridecadeoxynucleotide, process for its preparation and the application Dr. Karl Thomae GmbH (DE) 1982-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028368-A1 OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT NSUN2, RNGTT, POLR2H PDE3A 4766/4885PDE4D 4860/4885SLC29A1 405/4885
US-12459968-B2 Oligonucleotide synthesis on solid support RNGTT, SSU72, NSUN2 PDE3A 4799/4885PDE4D 4408/4885SLC29A1 229/4885
US-12559517-B2 Oligonucleotide manufacturing method POLL, IGF2BP1, POLI PDE3A 3104/4885PDE4D 2640/4885SLC29A1 1338/4885
US-20230119227-A1 OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT RNGTT, SSU72, NSUN2 PDE3A 4799/4885PDE4D 4408/4885SLC29A1 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.